Home Search
cancer - search results
If you're not happy with the results, please do another search
“Inadequate” UK cancer services risk late diagnosis for patients
According to a report, more than 340,000 cancer patients could face late diagnosis - due to NHS staff shortages.
Scientific sunburn & skin cancer (Part 2)
Chanda Siddoo-Atwal continues the discussion about scientific sunburn & skin cancer focusing on sunscreens that prevent scientific sunburn (apoptosis).
Visualising genomic instability in cancer
Sabine Mai and Aline Rangel-Pozzo from CancerCare Manitoba Research Institute, The University of Manitoba, explore how 3D imaging and quantitative analysis provide key insights into genomic instability.
Sabine Mai – CancerCare Manitoba Research Institute
https://www.chairs-chaires.gc.ca/chairholders-titulaires/profile-eng.aspx?profileId=4532
www.gccrd.ca
Therapeutic feline and canine cancer vaccine
Here we learn from Biljana Stangeland, PhD, Executive Director, Chief Scientific Officer and Co-founder at Alv B AS, about exciting new developments in therapeutic feline and canine cancer vaccine.
A new wave of molecular cancer therapeutics
Hernando Lopez-Bertoni, explores the new wave of molecular cancer therapeutics and states the case for learning the mechanisms as a pro, so one can target them as an artist.
Medical cannabis & the future of cancer treatments
Dr Stephen Barnhill MD, CEO of Apollon Formularies Plc, examines medical cannabis and the future of cancer treatments across the UK and the European healthcare sectors.
Ultrasounds to detect prostate cancer are highly successful
An ultrasound can diagnose most prostate cancer cases in men with great accuracy – only missing 3.4% of severe cases.
Examining intersectionality to find disparities in cancer care
Analysis of 28 studies has found that the intersection of sexual minority status with ethnicity is associated with lower cancer screenings.
Lower cancer risk in diets with lower meat intake
Researchers analysing dietary habits find that those who consume meat five times or less weekly have a lower cancer risk.
Reducing medical costs for inpatients with thyroid cancer
Professor Hiroki Konno at Nihon University explores proposals for reducing treatment costs for patients with thyroid cancer in Japan.
New potential therapy for aggressive bladder cancer
Led by Yale Cancer Center, new research shows that enfortumab vedotin is an effective alternative for patients with muscle-invasive bladder cancer (MIBC)
AI & cancer: Big data, big gains for medicine
Orlando Agrippa, CEO and Founder of RwHealth, turns the spotlight on AI and cancer, where big data brings big gains for medicine
Single cell cancer research
Chair of Medical Cell BioPhysics Leon WMM Terstappen highlights why the interrogation of the cancer cells at the single cell level is required to truly understand cancer development.
Non-melanoma skin cancer
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, describes the main focus of non-melanoma skin cancer, including its steadily rising incidence in the UK.
Drug for ovarian cancer shows 52% reduction in death
Scientists have began using trametinib – used to treat skin and lung cancers – for ovarian cancer, showing that it can significantly slow the progression of the cancer.
Scientists discover new treatment to fight pancreatic cancer
The potential pancreatic cancer treatment combines an ultrasound and immunotherapy method, with substantial "anti-cancer" benefits in lab mice.
Prospects for minimally invasive and optimally effective cancer immunotherapy
Here, Professor of Biochemistry, Microbiology & Immunology at the University of Saskatchewan, Peter Betscher, explains how he is dedicated towards realising Robert North’s vision.
Scientists use tumour-fighting cells to treat breast cancer
An ongoing clinical trial led by the NCI Centre for Cancer Research reveals an experimental form of immunotherapy for metastatic breast cancer.
Drug gives 34% protection against lung cancer recurrence
The NHS have gained a new drug, atezolizumab, which can give 34% protection against lung cancer recurrence or death, post-chemotherapy.
